Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;29(16):2400188.
doi: 10.2807/1560-7917.ES.2024.29.16.2400188.

Emergence of OXA-48-producing Klebsiella pneumoniae in Lithuania, 2023: a multi-cluster, multi-hospital outbreak

Affiliations

Emergence of OXA-48-producing Klebsiella pneumoniae in Lithuania, 2023: a multi-cluster, multi-hospital outbreak

Paulius Greičius et al. Euro Surveill. 2024 Apr.

Abstract

In 2023, an increase of OXA-48-producing Klebsiella pneumoniae was noticed by the Lithuanian National Public Health Surveillance Laboratory. Whole genome sequencing (WGS) of 106 OXA-48-producing K. pneumoniae isolates revealed three distinct clusters of carbapenemase-producing K. pneumoniae high-risk clones, including sequence type (ST) 45 (n = 35 isolates), ST392 (n = 32) and ST395 (n = 28), involving six, six and nine hospitals in different regions, respectively. These results enabled targeted investigation and control, and underscore the value of national WGS-based surveillance for antimicrobial resistance.

Keywords: Klebsiella pneumoniae; OXA-48; carbapenem-resistant Enterobacterales; carbapenemase; surveillance; whole genome sequencing.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure 1
Figure 1
Clusters of OXA-48-producing Klebsiella pneumoniae isolates by hospital, Lithuania, 2022–2023 (n = 106 isolates)
Figure 2
Figure 2
Epidemic curves for the three major Klebsiella pneumoniae clusters by hospital, Lithuania, 2022–2023 (n = 95 cases)
Figure 3
Figure 3
Meropenem minimal inhibitory concentration values for Klebsiella pneumoniae isolates from the three major clusters, Lithuania, 2022–2023 (n = 95 isolates)

References

    1. Ministry of Health of the Republic of Lithuania. Lietuvos Respublikos sveikatos apsaugos ministro įsakymas Nr. V-1194, priimtas 2013 m. gruodžio 18 d. Dėl Kliniškai ir epidemiologiškai svarbių mikroorganizmų atsparumo antimikrobiniams vaistams stebėsenos ir duomenų apie mikroorganizmų atsparumą antimikrobiniams vaistams rinkimo, kaupimo, analizės ir informacijos pateikimo tvarkos aprašo patvirtinimo. [Order No. V-1194 of the Minister of Health of the Republic of Lithuania of 18 December 2013. A description of procedures for the monitoring of antimicrobial resistance in clinically and epidemiologically relevant microorganisms and for the collection, compilation, analysis and reporting of antimicrobial resistance data]. Vilnius: Ministry of Health of the Republic of Lithuania; Register of Legal Acts. 31.12.2013: 2013-00188. Lithuanian. Available from: https://e-seimas.lrs.lt/portal/legalAct/lt/TAD/TAIS.463410/dqbCGVGruC
    1. European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST clinical breakpoints - Version 14.0. Växjö: EUCAST; 2024. Available from: https://www.eucast.org/clinical_breakpoints
    1. Jünemann S, Sedlazeck FJ, Prior K, Albersmeier A, John U, Kalinowski J, et al. Updating benchtop sequencing performance comparison. Nat Biotechnol. 2013;31(4):294-6. 10.1038/nbt.2522 - DOI - PubMed
    1. Souvorov A, Agarwala R, Lipman DJ. SKESA: strategic k-mer extension for scrupulous assemblies. Genome Biol. 2018;19(1):153. 10.1186/s13059-018-1540-z - DOI - PMC - PubMed
    1. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol. 2005;43(8):4178-82. 10.1128/JCM.43.8.4178-4182.2005 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources